Oregon Recalls THC Vape Pods Containing Unapproved Additives

Aug.24.2022
Oregon Recalls THC Vape Pods Containing Unapproved Additives
18,000 THC e-cigarette pods recalled in Oregon due to unauthorized non-cannabis additives, potentially causing respiratory issues.

During an investigation conducted by the Oregon Liquor Control Commission (OLCC) this month, it was found that over 18,000 THC (tetrahydrocannabinol) electronic cigarette pods sold in Oregon between November 2021 and July 2022 contained unapproved non-cannabis additives, which could potentially pose health issues for the respiratory system.


Here is what the recall for the electronic cigarettes shopping cart label looks like:


The marijuana regulatory agency in the state of Oregon has issued a recall for 18,000 electronic THC vape pods manufactured by YHN. The recall notice is printed on the back of the packaging (as shown in the photo from OLCC). The OLCC has initiated the recall of these pods, which were manufactured by YHN and sold in two stores located in the eastern Oregon town of Ontario.


Weedology and The Bud House are two pharmacies in Ontario that sell electronic cigarette pods. They have voluntarily pulled the recalled YHN products from their shelves. So far, the OLCC has not received any reports from consumers who have experienced negative health effects from using these YHN products.


We encourage consumers who have purchased unapproved products to return them to OLCC-licensed retailers or dispose of them. Individuals who have health concerns regarding recalled e-cigarette products should contact their healthcare provider.


The main culprit: Soybean oil.


As part of their ongoing independent investigation, officials from the OLCC tested a range of products from the YHN brand and found that some of their flavoring cartridges for inhalable cannabis may contain soybean oil, which contains triglycerides of glycerol and is prohibited for use in e-cigarette products in Oregon.


Soybean oil is considered a generally recognized as safe (GRAS) food additive by the U.S. Food and Drug Administration. However, this classification is based on ingestion rather than inhalation. When soybean oil is heated into vapor and inhaled, the triglycerides in it may cause various long and short-term health problems, including lipoid pneumonia, a rare lung disease that can cause lung inflammation and breathing difficulties.


Risk: Lipoid Pneumonia


According to data from the National Institutes of Health in the United States, the incidence of lipoid pneumonia is increasing with the rise of nicotine and tetrahydrocannabinol (THC) electronic cigarettes.


According to the National Institutes of Health, an electronic cigarette is defined as a device that uses heat to produce aerosol inhaled by the user from a liquid containing various chemicals, including but not limited to nicotine, artificial flavors, or marijuana. Their guidelines were last updated as of June 2022. A series of cases completed in North Carolina observed five previously healthy individuals who had no underlying conditions, experienced acute respiratory failure requiring hospitalization, and were found to frequently expose themselves to vaporized aerosol in July and August 2019.


In 2019, a vaping-related lung illness known as EVALI resulted in 60 deaths and over 2,800 hospitalizations. This illness was caused by the use of illegal THC vape pods containing vitamin E oil. While this oil has FDA approval for use in a variety of products, it is not suitable for inhalation via vaporization. In response to the EVALI outbreak, Oregon and other legal cannabis states have implemented strict regulations prohibiting certain additives such as vitamin E oil, squalene, and propylene glycol in cannabis vape pods.


Health risks associated with inhaling soybean oil have been observed in both food seasoning and production factories. In 2002, a microwave popcorn factory experienced a mysterious outbreak of bronchiolitis obliterans. Officials investigating the incident at the Centers for Disease Control and Prevention found that workers in the factory had lung problems caused by inhaling aerosolized byproducts of heated soybean oil.


Further punishment will depend on the intent of the production.


In the OLCC investigation into YHN's vape pod, flavors such as "Fruit Blend" and "Green Crack" were tested. Independent testing revealed the presence of ingredients that match those found in soybean oil, a substance banned for use in e-cigarettes in Oregon. It was also discovered that YHN's labeling only partially complied with Oregon's regulations for inhalable cannabinoid products.


The ingredient list of the YHN e-cigarette products that were recalled did indeed include artificial flavorings, and the products were correctly classified according to OLCC rules. However, YHN did not follow OLCC requirements to further break down the ingredients in their artificial flavorings to disclose the presence of soybean oil.


YHN may face a fine of $4,950 or have their marijuana license revoked. These are two very different outcomes, and the punishment may depend on whether OLCC determines that the prohibited additives were intentionally added or due to negligent oversight.


Announcement:


This article has been compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The article's translation is only intended for communication and research within the industry.


Due to limitations in the translator's proficiency, the compiled article may not express the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the position and statements of the Chinese government in relation to any issues pertaining to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09